148 related articles for article (PubMed ID: 12595497)
1. Production of the novel mesangial autocrine growth factors GDNF and IL-10 is regulated by the immunomodulator AS101.
Kalechman Y; Sredni B; Weinstein T; Freidkin I; Tobar A; Albeck M; Gafter U
J Am Soc Nephrol; 2003 Mar; 14(3):620-30. PubMed ID: 12595497
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of interleukin-10 by the immunomodulator AS101 reduces mesangial cell proliferation in experimental mesangioproliferative glomerulonephritis: association with dephosphorylation of STAT3.
Kalechman Y; Gafter U; Weinstein T; Chagnac A; Freidkin I; Tobar A; Albeck M; Sredni B
J Biol Chem; 2004 Jun; 279(23):24724-32. PubMed ID: 15001575
[TBL] [Abstract][Full Text] [Related]
3. Lipoxin A4 inhibits TNF-alpha-induced production of interleukins and proliferation of rat mesangial cells.
Wu SH; Lu C; Dong L; Zhou GP; He ZG; Chen ZQ
Kidney Int; 2005 Jul; 68(1):35-46. PubMed ID: 15954894
[TBL] [Abstract][Full Text] [Related]
4. The cyclin kinase inhibitor p57kip2 regulates TGF-beta-induced compensatory tubular hypertrophy: effect of the immunomodulator AS101.
Sinuani I; Weissgarten J; Beberashvili I; Rapoport MJ; Sandbank J; Feldman L; Albeck M; Averbukh Z; Sredni B
Nephrol Dial Transplant; 2009 Aug; 24(8):2328-38. PubMed ID: 19321762
[TBL] [Abstract][Full Text] [Related]
5. The rapamycin derivative RAD inhibits mesangial cell migration through the CDK-inhibitor p27KIP1.
Daniel C; Pippin J; Shankland SJ; Hugo C
Lab Invest; 2004 May; 84(5):588-96. PubMed ID: 15064772
[TBL] [Abstract][Full Text] [Related]
6. YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.
Chiang WC; Teng CM; Lin SL; Chen YM; Tsai TJ; Hsieh BS
Eur J Pharmacol; 2005 Jul; 517(1-2):1-10. PubMed ID: 15950964
[TBL] [Abstract][Full Text] [Related]
7. Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis.
Shankland SJ; Hugo C; Coats SR; Nangaku M; Pichler RH; Gordon KL; Pippin J; Roberts JM; Couser WG; Johnson RJ
Kidney Int; 1996 Oct; 50(4):1230-9. PubMed ID: 8887282
[TBL] [Abstract][Full Text] [Related]
8. Mesangial cell proliferation mediated by PDGF and bFGF is determined by levels of the cyclin kinase inhibitor p27Kip1.
Shankland SJ; Pippin J; Flanagan M; Coats SR; Nangaku M; Gordon KL; Roberts JM; Couser WG; Johnson RJ
Kidney Int; 1997 Apr; 51(4):1088-99. PubMed ID: 9083274
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 overexpression inhibits platelet-derived growth factor-induced mesangial cell proliferation through induction of the tumor suppressor gene p53 and the cyclin-dependent kinase inhibitors p21waf-1/cip-1 and p27kip-1.
Zahner G; Wolf G; Ayoub M; Reinking R; Panzer U; Shankland SJ; Stahl RA
J Biol Chem; 2002 Mar; 277(12):9763-71. PubMed ID: 11756433
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil and roscovitine decrease cyclin expression and increase p27(kip1) expression in anti Thy1 mesangial proliferative nephritis.
Chiara M; Menegatti E; Di Simone D; Davit A; Bellis D; Sferch D; De Rosa G; Giachino O; Sena LM; Roccatello D
Clin Exp Immunol; 2005 Feb; 139(2):225-35. PubMed ID: 15654821
[TBL] [Abstract][Full Text] [Related]
11. Lipoxins inhibit Akt/PKB activation and cell cycle progression in human mesangial cells.
Mitchell D; Rodgers K; Hanly J; McMahon B; Brady HR; Martin F; Godson C
Am J Pathol; 2004 Mar; 164(3):937-46. PubMed ID: 14982847
[TBL] [Abstract][Full Text] [Related]
12. PPARgamma ligand attenuates PDGF-induced mesangial cell proliferation: role of MAP kinase.
Ghosh SS; Gehr TW; Ghosh S; Fakhry I; Sica DA; Lyall V; Schoolwerth AC
Kidney Int; 2003 Jul; 64(1):52-62. PubMed ID: 12787395
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoids stimulate p21(CIP1) in mesangial cells and in anti-GBM glomerulonephritis.
Terada Y; Okado T; Inoshita S; Hanada S; Kuwahara M; Sasaki S; Yamamoto T; Marumo F
Kidney Int; 2001 May; 59(5):1706-16. PubMed ID: 11318941
[TBL] [Abstract][Full Text] [Related]
14. Ammonium trichloro(dioxoethylene-o,o')tellurate (AS101) sensitizes tumors to chemotherapy by inhibiting the tumor interleukin 10 autocrine loop.
Sredni B; Weil M; Khomenok G; Lebenthal I; Teitz S; Mardor Y; Ram Z; Orenstein A; Kershenovich A; Michowiz S; Cohen YI; Rappaport ZH; Freidkin I; Albeck M; Longo DL; Kalechman Y
Cancer Res; 2004 Mar; 64(5):1843-52. PubMed ID: 14996748
[TBL] [Abstract][Full Text] [Related]
15. Novel involvement of the immunomodulator AS101 in IL-10 signaling, via the tyrosine kinase Fer.
Hayun R; Shpungin S; Malovani H; Albeck M; Okun E; Nir U; Sredni B
Ann N Y Acad Sci; 2007 Jan; 1095():240-50. PubMed ID: 17404037
[TBL] [Abstract][Full Text] [Related]
16. Glial cell line-derived neurotrophic factor (GDNF) is expressed in the human kidney and is a growth factor for human mesangial cells.
Orth SR; Ritz E; Suter-Crazzolara C
Nephrol Dial Transplant; 2000 May; 15(5):589-95. PubMed ID: 10809797
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta1-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk 2 activation and retinoblastoma protein phosphorylation.
Schoecklmann HO; Rupprecht HD; Zauner I; Sterzel RB
Kidney Int; 1997 Apr; 51(4):1228-36. PubMed ID: 9083291
[TBL] [Abstract][Full Text] [Related]
18. EGF stimulates mesangial cell mitogenesis via PI3-kinase-mediated MAPK-dependent and AKT kinase-independent manner: involvement of c-fos and p27Kip1.
Mahimainathan L; Ghosh-Choudhury N; Venkatesan BA; Danda RS; Choudhury GG
Am J Physiol Renal Physiol; 2005 Jul; 289(1):F72-82. PubMed ID: 15701816
[TBL] [Abstract][Full Text] [Related]
19. Insulin is a potent survival factor in mesangial cells: role of the PI3-kinase/Akt pathway.
Hiromura K; Monkawa T; Petermann AT; Durvasula RV; Shankland SJ
Kidney Int; 2002 Apr; 61(4):1312-21. PubMed ID: 11918738
[TBL] [Abstract][Full Text] [Related]
20. Delay in the onset of systemic lupus erythematosus following treatment with the immunomodulator AS101: association with IL-10 inhibition and increase in TNF-alpha levels.
Kalechman Y; Gafter U; Da JP; Albeck M; Alarcon-Segovia D; Sredni B
J Immunol; 1997 Sep; 159(6):2658-67. PubMed ID: 9300685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
